Oncodesign Precision Medicine SA

11/21/2022 | Press release | Distributed by Public on 11/21/2022 01:05

Oncodesign Precision Medicine (OPM) annonce le lancement d’une augmentation de capital avec délai de priorité pour les actionnaires ainsi que son transfert sur Euronext Growth[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.